Company profile
IFM Therapeutics company profile
IFM Therapeutics is a provider of small molecule that module novel targets in the innate immune system. The company and its academic collaborators combine unparalleled expertise in innate immunity with seasoned drug discovery and development professionals. Its subsidiary IFM Due is focused on the discovery and developing antagonists of the cGAS/STING pathway for the treatment of inflammation, neuroinflammation, autoimmunity and cancer. IFM Discovery, a newly financed incubator entity within the IFM enterprise, is prosecuting a basket of genetically-validated targets as next-generation therapies for inflammation, neuroinflammation, autoimmunity and fibrosis
Business identity
- Website
- https://www.ifmthera.com/
- Contact email
- [email protected]
- Phone number
- +1-857-327-9903
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $1M-$10M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Panora, Iowa, United States
- Postal code
- 02199
- Country code
- US
- Continent
- North America